A Medical Device Daily Staff Report
Teleflex (Limerick, Pennsylvania), a provider of medical devices for critical care and surgery, reported a new agreement with Premier Purchasing Partners, the group purchasing unit of the Premier (Charlotte, North Carolina) healthcare alliance. The new agreement covers Teleflex's Arrow brand of intra-aortic balloon catheters and pumps (IABP). It begins Nov. 1 and extends through Oct. 31, 2014. Arrow claims the AutoCAT 2 series of IABPs, designed to meet the range of customer requirements and patient conditions, represent the most technologically advanced cardiac assist consoles on the market today. Used to support patients whose native or pharmacologically-assisted cardiac output is unable to meet the body's tissue perfusion needs, Arrow's balloon pump consoles offer full automaticity of the most critical functions, responding to changes in patient conditions to maintain the desired level of hemodynamic support.
The only console with the physiologically derived WAVE algorithm, developed by physician scientists and peer-reviewed in professional medical journals, this system is designed to support the sickest of cardiac patients; those with fast and erratic heart rhythms as well as those patients with slow and regular heart rhythms. In one study, the AutoCAT 2 WAVE IABP demonstrated a 98% accuracy rate in inflating the balloon catheter within several milliseconds of the target physiologic event. With one button start-up and full support initiated within 5 seconds, both physicians and clinicians can focus on the patient's needs and not the support device's function.
"Teleflex's Cardiac Care team has a long history of working closely with physicians to provide products that help to improve patient outcomes," said Howard Miller, president, cardiac care division. "We welcome the opportunity to work with Premier members in bringing this critical therapy to their patients."
Premier maintains a repository of clinical, financial and outcomes information and operates a healthcare purchasing network.
In other agreements/contracts news:
• RaySearch Laboratories (Stockholm, Sweden) has received an order for its RayStation treatment planning system from The University Hospital of Columbia and Cornell (New York). RayStation will serve as an advanced research platform at the University Hospital Department of Radiation Oncology where the staff will use the system to model advanced workflows in multi-criteria optimization IMRT, 4-D image registration and dose accumulation as well as other cutting edge technologies.
"RayStation is a clinical treatment planning system built by a very powerful development organization. The fact that we have more than 60 developers with expertise in image processing, optimization and usability analysis provides a unique opportunity for our collaborators to move their projects from investigation into clinical use. We are delighted at the opportunity to work with Hansen and the team at the University Hospital," said Marc Mlyn, president of RaySearch Americas.
RayStation combines features such as multi-criteria optimization tools with full support for 4-D adaptive radiation therapy.
• Corgenix Medical (Denver), a maker of diagnostic test kits, has entered into a U.S. distribution agreement with AXA Diagnostics (Pomezia, Italy). Corgenix will market AXA Diagnostics' proprietary SkyLAB 752 ELISA/IFA Analyzer on a non-exclusive basis in the U.S.
The SkyLAB 752 is the first automated microplate processing instrument that can independently multitask, performing all functions at the same time. The new ELISA (enzyme-linked immunosorbent assay) and IFA (immunofluorescence assay) platform can process up to 7 microplates or 28 IFA slides simultaneously. Due to its pipetting system the SkyLAB 752 can process Corgenix rapid ELISA tests for significant time and cost savings to the laboratories, giving Corgenix products a significant advantage over competitive test kits with longer incubation times.
Corgenix makes specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. AXA Diagnostics is a private company that makes instrumentation and specialized diagnostic tests, with an emphasis on autoimmune in vitro diagnostic products.
Rochester Medical moves HQ to Noblesville
Rochester Medical Implants (Noblesville, Illinois), a contract manufacturer of orthopedic implants and precision products, has relocated corporate offices and manufacturing operations to their new facility in Noblesville. In acknowledgement of the location change, the company will change its name to RMI.
The new facility is a modern 33,000-square foot building providing increased capacity and opportunity for enhanced capabilities and services. All CNC equipment has been relocated and additional capital purchases are planned. The building is conveniently located in the Indianapolis metropolitan area and offers improved customer access.